{"cik":"0001839285","entityName":"HEALTHCARE TRIANGLE, INC.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-11-14","val":0,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":4349638,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2632143,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"AccountsReceivableNet":{"label":"Accounts Receivable, after Allowance for Credit Loss","description":"Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.","units":{"USD":[{"end":"2020-12-31","val":6396150,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":5909429,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"AccountsReceivableNetCurrent":{"label":"Accounts Receivable, after Allowance for Credit Loss, Current","description":"Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.","units":{"USD":[{"end":"2020-12-31","val":6396150,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":5909429,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":{"label":"Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment","description":"Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.","units":{"USD":[{"end":"2020-12-31","val":72004,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":66067,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":1042021,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1924854,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"AdvertisingExpense":{"label":"Advertising Expense","description":"Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":47353,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"AmortizationOfIntangibleAssets":{"label":"Amortization of Intangible Assets","description":"The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":194384,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":206320,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":11107563,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":11391051,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":8027698,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":8512823,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"BusinessDevelopment":{"label":"Business Development","description":"Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":550167,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":2204030,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2019-12-31","val":974832,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2019Q4I"},{"end":"2020-09-30","val":174955,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3I"},{"end":"2020-12-31","val":1402700,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1148429,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect","description":"Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-799877,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":-254271,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"CashFDICInsuredAmount":{"label":"Cash, FDIC Insured Amount","description":"The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.","units":{"USD":[{"end":"2021-09-30","val":250000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.00001,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.00001,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":100000000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":100000000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":27900000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":29988750,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":27900000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":29988750,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":279,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":300,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"ContractWithCustomerAssetNetCurrent":{"label":"Contract with Customer, Asset, after Allowance for Credit Loss, Current","description":"Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.","units":{"USD":[{"end":"2021-09-30","val":763601,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"ContractWithCustomerLiability":{"label":"Contract with Customer, Liability","description":"Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.","units":{"USD":[{"end":"2020-12-31","val":749029,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":266975,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"ConvertibleDebt":{"label":"Convertible Debt","description":"Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":4244940,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"ConvertibleNotesPayableCurrent":{"label":"Convertible Notes Payable, Current","description":"Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.","units":{"USD":[{"end":"2020-12-31","val":754400,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1952672,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"CostOfRevenue":{"label":"Cost of Revenue","description":"The aggregate cost of goods produced and sold and services rendered during the reporting period.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":16162776,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":5358695,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":17828791,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":5351748,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"CurrentFederalTaxExpenseBenefit":{"label":"Current Federal Tax Expense (Benefit)","description":"Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":35938,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"CurrentIncomeTaxExpenseBenefit":{"label":"Current Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":51340,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":942,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"CurrentStateAndLocalTaxExpenseBenefit":{"label":"Current State and Local Tax Expense (Benefit)","description":"Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":15402,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":942,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"DebtInstrumentInterestRateDuringPeriod":{"label":"Debt Instrument, Interest Rate During Period","description":"The average effective interest rate during the reporting period.","units":{"pure":[{"start":"2021-01-01","end":"2021-09-30","val":0.1,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"DeferredRevenue":{"label":"Deferred Revenue","description":"Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.","units":{"USD":[{"end":"2020-12-31","val":297775,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":266975,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"DepreciationAndAmortization":{"label":"Depreciation, Depletion and Amortization, Nonproduction","description":"The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":603567,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":200864,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":633290,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":211328,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"DepreciationDepletionAndAmortization":{"label":"Depreciation, Depletion and Amortization","description":"The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":603567,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":633290,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"DueFromAffiliateCurrent":{"label":"Due from Affiliate, Current","description":"Amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership, due within 1 year (or 1 business cycle).","units":{"USD":[{"end":"2020-12-31","val":445003,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":826303,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"DueFromRelatedParties":{"label":"Due from Related Parties","description":"For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.","units":{"USD":[{"end":"2020-12-31","val":445003,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":826303,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"EarningsPerShareBasic":{"label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":0.017,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":0.005,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-0.087,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-0.069,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"EarningsPerShareDiluted":{"label":"Earnings Per Share, Diluted","description":"The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":0.017,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":0.005,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-0.087,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-0.069,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"EffectiveIncomeTaxRateContinuingOperations":{"label":"Effective Income Tax Rate Reconciliation, Percent","description":"Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.","units":{"pure":[{"start":"2020-01-01","end":"2020-09-30","val":0.27,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"ExtendedProductWarrantyAccrualCurrent":{"label":"Extended Product Warranty Accrual, Current","description":"Amount at end of the reporting period of the aggregate extended product warranty liability that is expected to be paid within one year of the balance sheet date or normal operating cycle, if longer. Does not include the balance for the standard product warranty liability.","units":{"USD":[{"end":"2020-12-31","val":885600,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2347616,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"FairValueAdjustmentOfWarrants":{"label":"Fair Value Adjustment of Warrants","description":"Amount of expense (income) related to adjustment to fair value of warrant liability.","units":{"USD":[{"start":"2021-07-01","end":"2021-09-30","val":2347616,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"FederalIncomeTaxExpenseBenefitContinuingOperations":{"label":"Federal Income Tax Expense (Benefit), Continuing Operations","description":"Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-123796,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":-35938,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"}]}},"FiniteLivedIntangibleAssetsAccumulatedAmortization":{"label":"Finite-Lived Intangible Assets, Accumulated Amortization","description":"Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.","units":{"USD":[{"end":"2020-12-31","val":1507322,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2126282,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths":{"label":"Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months","description":"Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.","units":{"USD":[{"end":"2021-09-30","val":825280,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree":{"label":"Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three","description":"Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.","units":{"USD":[{"end":"2021-09-30","val":349556,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo":{"label":"Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two","description":"Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.","units":{"USD":[{"end":"2021-09-30","val":825280,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"FiniteLivedIntangibleAssetsGross":{"label":"Finite-Lived Intangible Assets, Gross","description":"Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.","units":{"USD":[{"end":"2020-12-31","val":4126398,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":4126398,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"FiniteLivedIntangibleAssetsNet":{"label":"Finite-Lived Intangible Assets, Net","description":"Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.","units":{"USD":[{"end":"2020-12-31","val":2619076,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2000116,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":2326341,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":582874,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":3061785,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":753338,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"IncomeLossFromContinuingOperations":{"label":"Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent","description":"Amount after tax of income (loss) from continuing operations attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":678507,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":191310,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-2018852,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-1770495,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":{"label":"Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest","description":"Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":653587,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":190149,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-2498701,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-1991129,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments":{"label":"Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest","description":"Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":653587,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":190149,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-2498701,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-1991129,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"IncomeLossFromContinuingOperationsPerBasicShare":{"label":"Income (Loss) from Continuing Operations, Per Basic Share","description":"The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":0.017,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":0.005,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-0.087,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-0.069,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"IncomeLossFromContinuingOperationsPerDilutedShare":{"label":"Income (Loss) from Continuing Operations, Per Diluted Share","description":"The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":0.017,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":0.005,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-0.087,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-0.069,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"IncomeTaxExpenseBenefit":{"label":"Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":176605,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":51340,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":4759,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":942,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities":{"label":"Increase (Decrease) in Accounts Payable and Accrued Liabilities","description":"The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-2547978,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":-1717495,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"IncreaseDecreaseInAccountsReceivable":{"label":"Increase (Decrease) in Accounts Receivable","description":"The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-665348,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":-486721,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"IncreaseDecreaseInContractWithCustomerAsset":{"label":"Increase (Decrease) in Contract with Customer, Asset","description":"Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":763601,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"IncreaseDecreaseInDeferredRevenue":{"label":"Increase (Decrease) in Deferred Revenue","description":"Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-749029,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":-30800,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"IncreaseDecreaseInDueFromRelatedParties":{"label":"Increase (Decrease) in Due from Related Parties","description":"The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1040145,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":381300,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"IncreaseDecreaseInOtherCurrentAssets":{"label":"Increase (Decrease) in Other Current Assets","description":"Amount of increase (decrease) in current assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":85584,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":462516,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"IncreaseDecreaseInOtherCurrentLiabilities":{"label":"Increase (Decrease) in Other Current Liabilities","description":"Amount of increase (decrease) in current liabilities classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":674950,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":-76429,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"InterestExpense":{"label":"Interest Expense","description":"Amount of the cost of borrowed funds accounted for as interest expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":24920,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":1161,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":479849,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":220634,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"InterestExpenseDebt":{"label":"Interest Expense, Debt","description":"Amount of the cost of borrowed funds accounted for as interest expense for debt.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":24920,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":1161,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":479849,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":220634,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"InterestExpenseLongTermDebt":{"label":"Interest Expense, Long-term Debt","description":"Aggregate amount of interest paid or due on all long-term debt.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-07-01","end":"2021-09-30","val":106996,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":6779193,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":8683287,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":11107563,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":11391051,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":6779193,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":8683287,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"MarketingAndAdvertisingExpense":{"label":"Marketing and Advertising Expense","description":"The total expense recognized in the period for promotion, public relations, and brand or product advertising.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1103486,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":476650,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":2801188,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":1328399,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1183395,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":3673470,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":18617,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":-50354,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-2001889,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":-3877388,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":476983,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":138809,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-2503460,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-1992071,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"NetIncomeLossAvailableToCommonStockholdersBasic":{"label":"Net Income (Loss) Available to Common Stockholders, Basic","description":"Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":476981,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":138808,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-2503460,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-1992071,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"NonoperatingIncomeExpense":{"label":"Nonoperating Income (Expense)","description":"The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-24920,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":-1161,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-479849,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-220634,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":678507,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":191310,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-2018852,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-1770495,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"OperatingLeasesRentExpenseNet":{"label":"Operating Leases, Rent Expense, Net","description":"Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":41703,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":54177,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"OtherAssetsCurrent":{"label":"Other Assets, Current","description":"Amount of current assets classified as other.","units":{"USD":[{"end":"2020-12-31","val":228848,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":691364,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"OtherLiabilitiesCurrent":{"label":"Other Liabilities, Current","description":"Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":491780,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":415351,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"PaymentsForProceedsFromProductiveAssets":{"label":"Payments for (Proceeds from) Productive Assets","description":"The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-18617,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":50354,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"PreferredStockNoParValue":{"label":"Preferred Stock, No Par Value","description":"Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD/shares":[{"end":"2020-12-31","val":0.00001,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.00001,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":10000000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":10000000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"ProceedsFromConvertibleDebt":{"label":"Proceeds from Convertible Debt","description":"The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":2604940,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"ProfitLoss":{"label":"Net Income (Loss), Including Portion Attributable to Noncontrolling Interest","description":"The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":476983,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":138809,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-2503461,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-1992071,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"PropertyPlantAndEquipmentGross":{"label":"Property, Plant and Equipment, Gross","description":"Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2020-12-31","val":87790,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":117876,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"PropertyPlantAndEquipmentNet":{"label":"Property, Plant and Equipment, Net","description":"Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2020-12-31","val":15786,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":51809,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"RepaymentsOfRelatedPartyDebt":{"label":"Repayments of Related Party Debt","description":"The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":96262,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":49272,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1469416,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":550167,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":3774712,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":2204030,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"RetainedEarningsAppropriated":{"label":"Retained Earnings, Appropriated","description":"A segregation of retained earnings which is unavailable for dividend distribution. Includes also retained earnings appropriated for loss contingencies.","units":{"USD":[{"end":"2020-12-31","val":3286070,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":782609,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"RevenueFromContractWithCustomerIncludingAssessedTax":{"label":"Revenue from Contract with Customer, Including Assessed Tax","description":"Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":22344093,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":7360560,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":26080914,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":8078348,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"Revenues":{"label":"Revenues","description":"Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":22344093,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":7360560,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":26080914,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":8078348,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-01-01","end":"2021-09-30","val":19087,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price","description":"Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.","units":{"USD/shares":[{"end":"2021-09-30","val":0.4,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate","description":"The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.","units":{"pure":[{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number","description":"The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.","units":{"shares":[{"end":"2021-09-30","val":2266500,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2020-12-31","val":4000000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1733500,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"SharesIssued":{"label":"Shares, Issued","description":"Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":25500000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"}]}},"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations":{"label":"State and Local Income Tax Expense (Benefit), Continuing Operations","description":"Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-52808,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":-15402,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-4759,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":-942,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2020-12-31","val":4328370,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2707764,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest":{"label":"Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest","description":"Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.","units":{"USD":[{"end":"2019-12-31","val":1974927,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2019Q4I"},{"end":"2020-06-30","val":2313101,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q2I"},{"end":"2020-09-30","val":2451910,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3I"},{"end":"2020-12-31","val":4328370,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q4I"},{"end":"2021-06-30","val":4444746,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q2I"},{"end":"2021-09-30","val":2707763,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3I"}]}},"StockIssuedDuringPeriodValueIssuedForServices":{"label":"Stock Issued During Period, Value, Issued for Services","description":"Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":735499,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":135999,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"WeightedAverageNumberOfDilutedSharesOutstanding":{"label":"Weighted Average Number of Shares Outstanding, Diluted","description":"The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":27900000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":27900000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":28839889,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":28839889,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":27900000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":27900000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":28839889,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":28839889,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}},"WeightedAverageNumberOfSharesOutstandingBasic":{"label":"Weighted Average Number of Shares Outstanding, Basic","description":"Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":27900000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2020-07-01","end":"2020-09-30","val":27900000,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":28839889,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23"},{"start":"2021-07-01","end":"2021-09-30","val":28839889,"accn":"0001607062-21-000554","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-23","frame":"CY2021Q3"}]}}}}}